Commentary on Bade et al.: Threat of nitazenes and other potent synthetic opioids—Is Europe prepared? Time to respond and to learn

Documents similaires

• The emergence of nitazenes on the Irish heroin market and national preparation for possible future outbreaks
  par: Nicki Killeen, et autres
  Publié: (2024)
• Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: Two years of data from 22 countries
  par: Richard Bade, et autres
  Publié: (2025)
• Commentary on Stam et al .: The substantial and dynamic contribution of opioid potency to total overdose risk
  par: Phillip O. Coffin
  Publié: (2024)
• Commentary on Gregory et al .: Fear of precipitated opioid withdrawal should not prevent buprenorphine initiation
  par: Sandra A. Springer
  Publié: (2024)
• Commentary on Young et al .: Clinical guidance is required for stimulant co‐prescription with opioid agonist therapy
  par: Nadine Ezard, et autres
  Publié: (2025)